Coverage in Forbes describing Exscientia's $4.2 Million grant from The Gates Foundation to develop new medicines and treatments.
For the article our Portfolio Manager Denise (Barrault) was interviewed by Marija Butkovic.
See original article here
Coverage in Forbes describing Exscientia's $4.2 Million grant from The Gates Foundation to develop new medicines and treatments.
For the article our Portfolio Manager Denise (Barrault) was interviewed by Marija Butkovic.
See original article here